1. Home
  2. WTO vs PRFX Comparison

WTO vs PRFX Comparison

Compare WTO & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTO

UTime Limited

HOLD

Current Price

$0.72

Market Cap

2.4M

Sector

Technology

ML Signal

HOLD

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$0.79

Market Cap

2.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTO
PRFX
Founded
2008
2007
Country
China
Israel
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
WTO
PRFX
Price
$0.72
$0.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
726.3K
119.8K
Earning Date
01-27-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,589,265.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
54.01
N/A
52 Week Low
$0.55
$0.61
52 Week High
$344.60
$6.65

Technical Indicators

Market Signals
Indicator
WTO
PRFX
Relative Strength Index (RSI) 48.33 45.58
Support Level $0.66 $0.66
Resistance Level $0.91 $0.92
Average True Range (ATR) 0.11 0.08
MACD -0.01 0.01
Stochastic Oscillator 32.62 56.19

Price Performance

Historical Comparison
WTO
PRFX

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: